On February 5, 2020, San Francisco-based Verana Health, a tech start-up curating and analyzing real-world clinical data to advance patient care, announced it has acquired the technology assets and team behind PYA Analytics (PYAA), which specializes in large-scale data architecture solutions. Additionally, Verana announced the close of a $100 million investment led by GV; new investors Bain Capital Ventures, Casdin Capital, and Define Ventures also participated in the round along with the company's existing slate of investors. Wilson Sonsini Goodrich & Rosati represented Verana in both transactions.

"Verana is assembling the most comprehensive datasets in medicine across multiple disease types with the goal of accelerating medical research for patients with ophthalmic and neurologic conditions,” said Miki Kapoor, CEO of the Verana Health. "The financing and the addition of PYAA enable us to enrich these large clinical databases, creating a longitudinal view of the complete patient journey to inform research and patient care.”

The PYAA team will remain at its base in Knoxville, Tennessee; Verana plans to hire and grow the office in the coming months. Verana also intends to further scale its San Francisco headquarters and New York office in the coming year.

The Wilson Sonsini team representing Verana Health in both transactions includes corporate partner Megan Baier and associates Catherine Riley Tzipori, and employee benefits & compensation partner Sriram Krishnamurthy and associate Matt Norgard.

For more information, please see Verana Health's press release.